HKEX Stock Code: 01093English|繁體|简体

Highlight - 2024 1H

Revenue
RMB16,284M, +1.3%
Underlying profit attributable to shareholders
RMB3,217M, +1.7%
Reported profit attributable to shareholders
RMB3,020M, +1.8%
Basic earnings per share (reported)
RMB25.51 cents, +2.2%
Basic earnings per share (underlying profit)
RMB27.17 cents, +2.2%

Key Products

Finished drugs
Bulk drugs
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.